Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-30Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-06-03265 Self-reported rates of psilocybin use in North Florida, 2012 to presentUnknown journal · 2026-05-19Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-061020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme DiseaseSLEEP · 2026-04-30Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant EffectsbioRxiv · 2026-04-21A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-03Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.Neurologic clinics · 2026-01-31The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-24Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trialHeadache The Journal of Head and Face Pain · 2025-12-28Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Griffiths et al.’s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian PerspectivePsychedelic Medicine · 2025-11-30Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-14The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceJournal of Neuroscience · 2025-11-09Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Unknown journal · 2025-10-30Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in ratsBehavioural Pharmacology · 2025-09-24Psychedelics Relax Priors and Reshape Orbitofrontal DynamicsbioRxiv · 2025-09-18Active Constituents of Psilocybin Mushroom EdiblesJAMA Network Open · 2025-09-10Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-15Prolonged hallucinogenic effects following Psilocybe cubensis ingestion: Case reportThe poison. · 2025-06-29Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot studyJournal of Affective Disorders · 2025-06-08Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushroomsAmerican Journal of Ophthalmology Case Reports · 2025-06-01Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatmentsPsyArXiv · 2025-05-15Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-23630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label StudyBiological Psychiatry · 2025-04-08Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)Neurology · 2025-04-06The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortexMolecular Brain · 2025-03-17Psilocybin for disorders of consciousness: A case-report studyClinical Neurophysiology · 2025-03-07Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.Unknown journal · 2025-02-28Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31Prevalence of Use of Psilocybin and MDMA in Multiple US CitiesDrug and Alcohol Dependence · 2025-01-31Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.Addiction (Abingdon, England) · 2025-01-15Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.Unknown journal · 2025-01-14Political Attitudes towards the Legalization of Cannabis and PsilocybinSSRN Electronic Journal · 2024-12-31Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label TrialAmerican Journal of Psychiatry · 2024-12-31High-quality draft genomes of ecologically and geographically diverse Psilocybe speciesMicrobiology Resource Announcements · 2024-12-26ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trialPsyArXiv · 2024-11-03Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administrationUNC Libraries · 2024-10-21Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot studyJournal of Affective Disorders · 2024-09-26Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.Unknown journal · 2024-09-11Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction RelapseThe Journal of Clinical Psychiatry · 2024-08-24PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical TrialClinicalTrials.gov · 2024-08-08Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022Drug and Alcohol Dependence · 2024-06-30Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-06-30Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-06-30THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptoriScience · 2024-04-08Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trialJournal of the Neurological Sciences · 2024-04-01The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderPLoS ONE · 2024-03-13Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Unknown journal · 2024-02-15New evidence for flexible psilocybin dosing in patients with treatment-resistant depressionMed · 2024-02-13National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022Drug and Alcohol Dependence · 2024-02-05Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?University of Zagreb University Computing Centre (SRCE) · 2023-12-31Psilocybin Without Psychotherapy: A Cart Without a Horse?Unknown journal · 2023-12-31CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivityHeadache The Journal of Head and Face Pain · 2023-12-31Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2023-12-17A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.Chembiochem: a European journal of chemical biology · 2023-11-01Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Unknown journal · 2023-10-04A suite of engineered mice for interrogating psychedelic drug actionsbioRxiv · 2023-09-25Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2023-08-31Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSDBMJ Open · 2023-04-30Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-2496. An Open Label Study of Synthetic Psilocybin in Bipolar Type II DepressionBiological Psychiatry · 2023-04-09Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.Journal of bioethical inquiry · 2023-02-28Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparationJournal of Affective Disorders · 2023-01-24Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?Pharmaceuticals · 2022-12-30Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache The Journal of Head and Face Pain · 2022-11-22Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS Pharmacology & Translational Science · 2022-11-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.Unknown journal · 2022-10-11Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16[The use of psilocybin for treatment-resistant depression].Unknown journal · 2022-08-31Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-07-31Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.ChemBioChem · 2022-05-17Psilocybin-induced takotsubo cardiomyopathy.BMJ Case Reports · 2022-05-16P388. Open Label Psilocybin Administration in Severely Treatment Resistant DepressionBiological Psychiatry · 2022-04-27The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use DisordersCanadian Agency for Drugs and Technologies in Health, Ottawa (ON) · 2021-05-31Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Proceedings of the National Academy of Sciences · 2021-03-31Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," Athelia (Fibularhizoctonia) sp. TMB Strain TB5.Microbiology Resource Announcements · 2021-01-06Exploratory Controlled Study of the Migraine-Suppressing Effects of PsilocybinNeurotherapeutics · 2020-11-11[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]Unknown journal · 2020-11-11A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted TherapyPsyArXiv · 2020-10-27Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in “Magic” MushroomsChemistry - A European Journal · 2019-11-13Replication and extension of a model predicting response to psilocybinPsychopharmacology · 2019-06-14Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybinNeuroImage · 2019-05-23Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.Unknown journal · 2018-12-11Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in Psychology · 2018-12-05Entheogene Pilze: Welches Potential bietet die psychoaktive Substanz Psilocybin für die moderne Psychotherapie in Forschung und Praxis? / Sophie-Charlotte Alice AdlerUnknown journal · 2018-07-31Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-24High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of Psychopharmacology · 2018-06-26Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical Pharmacokinetics · 2017-11-30Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Journal of Psychoactive Drugs · 2015-11-22Availability of websites offering to sell psilocybin spores and psilocybin.Journal of Psychoactive Drugs · 2009-08-31Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.Unknown journal · 2004-05-31Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.Unknown journal · 1990-03-31The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography.Unknown journal · 1983-09-30Severe aggression in rats induced by mescaline but not other hallucinogens.Unknown journal · 1978-12-31Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.Unknown journal · 1976-06-30The psilocybin producer's guideUnknown journal · 1976-02-28The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.Unknown journal · 1962-04-30Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen RauschpilzenHelvetica Chimica Acta · 1958-12-31[Elucidation of the structure and the synthesis of psilocybin].Unknown journal · 1958-10-31